SUMMARY Three patients are described in whom irradiation of 2750 rad or more was used in the management of primary brain tumours, and 21 years or more later a second brain tumour of a different type occurred. One of the new tumours was a meningioma and the other two were cerebral astrocytomas. There is evidence to show that moderate doses of ionising radiations given in childhood for tinea capitis are associated with a late risk of developing a meningioma. Higher doses of radiation used for tumours in childhood are followed also by a late hazard of meningioma. There is insufficient evidence to implicate ionising radiations in the aetiology of gliomas. The oncogenic hazards of radiotherapy to the brain do not outweigh its therapeutic value in brain tumour.
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Although the simultaneous occurrence of two primary brain tumours of either the same or different types is recognised but not common, the consecutive development of brain tumours after a long time interval has rarely been recorded (Behrend, 1974) . So far, most have been in the phakomatoses. While ionising radiations are a potent carcinogen, only exceptionally have they been postulated in the aetiology of brain tumours. In this paper I report three patients with primary brain tumour who 21 years or more later had a second brain tumour of a different type. All had been given radiotherapy as part of their initial treatment.
Patients CASE 1
A male (NS 573) , born on 1 February 1935, had a two year history of headaches and recent vomiting and diplopia when he was admitted on 5 January 1945. There was papilloedema, left sixth cranial nerve palsy, and mild generalised ataxia.
Ventriculography showed a round mass in the posterior end of the third ventricle which contained a little calcium. A posterior fossa craniotomy revealed no abnormality. On recovery the patient was given radiotherapy to the pineal region from a 200 kV source. The estimated dose was 4000 rad given over 23 days through multiple ports.
He (Fig. 1) . He died at home on 9 December 1971. A limited necropsy was done.
The fixed brain weighed 1200 g. The dura mater was adherent to the right frontal and parietal areas. On serial section there was an extensive neoplasm in the right hemisphere which had spread into the left (Fig. 2) : p i n e a l teratoma and benign (Russell and 6A'* s~~~~~Rubinstein, 1971 (Schoenberg et al., 1969) (Schoenberg et al., 1969) . Should a third cancer develop then there is a susceptibility to cancer (Moertal, 1966) .
Leaving the phakomas aside, simultaneous brain tumours of a wide variety are known but not common, but whether this is more than a chance finding is unknown (Russell and Rubinstein, 1971; Behrend, 1974) . The natural expectancy for a primary brain tumour is of the order of 8.5/10 000 population per year for all ages (Kurland, 1958) . The adult expectancy for a glioma is 3.9/100000 population per year, and that for a meningioma is 1.23/100 000 (Barker et al., 1976) . Whether the late possibility of a second brain tumour reaches natural expectancy has never been studied. Radiotherapy has enabled some patients with brain tumour in childhood to have prolonged survival, and patients may live for long periods after the treatment of a pituitary adenoma or a meningioma. It is these patients who are at risk for second brain tumour, but accurate data are lacking. In the nature of things gliomas should considerably outnumber meningiomas in the sequential situation.
Experimentally it is very difficult to induce tumours in the primate nervous system by whatever carcinogen is used. A few brain tumours have been induced by ionising radiations in monkeys in whom natural brain tumours are rare -five instances in 115 000 monkeys (Haymaker et al., 1972) . A glioblastoma multiforme in a Macacca mulatta was induced nearly two and a half years after exposure of the head to thermal neutrons (Kent and Pickering, 1958) . When wholebody protons 600-800 rad were given to M. mulatta, three glioblastomas were produced three to five years later. For animals who survived more than two years the risk was in excess of natural expectancy (Traynor and Casey, 1971; Haymaker et al., 1972) .
In man, irradiation of the head in childhood may be followed many years later by a brain tumour, usually a meningioma. An obsolescent method of treating tinea capitis was to irradiate the scalp with 500-800 rad when the surface dose to the brain is about 140 rad. The treatment was used widely for nearly half a century from 1909 onwards until superseded by griseofulvin. It was not until 1966 that the serious long-term hazards of this treatment were reported. Of the nine neoplasms found in 1548 irradiated children there was one astrocytoma of the optic nerve and chiasma, and one cerebral astrocytoma (Albert et al., 1966) . Then followed a report from Israel of five cases of intracranial meningioma after this treatment with latencies of 16 to 50 years (Munk et al., 1969) , and there was another series of 16 cases (Beller et al., 1972) . Nearly 16500 child immigrants to Israel in the period 1948-1951 were so treated, and from an analysis of some 11 000 of these cases there is conclusive evidence of the role of such irradiation in the aetiology of brain tumour, particularly meningioma. The meningioma rate was 0.4/1000 cases in the irradiated cases against 0.1/1000 in the non-irradiated, a statistically significant difference. There was an excess of other brain tumours over the expected rate but not at significant levels (Modan et al., 1974) . Probably not dissimilar dose-wise was the sphenoidal ridge meningioma that appeared 24 years after thorium dioxide ventriculography in childhood (Kyle et al., 1963) . There is a report of a meningioma occurring 28 years after application of radium to the scalp for a vascular naevus in childhood (Feiring and Foer, 1968) .
Seven intracranial meningiomas have been reported after earlier high-dose irradiation for other types of brain tumour when the dose was 2300 rad or more. Six cases were in children or adolescents (Gautier-Smith, 1970 , one case; Norwood et al., 1974, two cases; Bogdanowicz and Sachs, 1974, two cases; Tanaka et al., 1975 , one case), and the seventh was in a young adult (Waga and Handa, 1976) . The latent intervals between the two tumours were from 12 to 15 years. Our case 3 would be the eighth such case and the latent interval was 22 years. Also, it is likely that the meningeal sarcoma reported by Bojsen-M0ller and Knudsen (1977) could be a meningioma, and this was a childhood case.
Occasionally sarcoma, often soft tissue, may follow therapeutic irradiation of the head. In a review by Waltz and Brownell (1966) there were 13 cases of sarcoma mainly in the sellar region after radiotherapy for pituitary adenoma, with latencies of two and a half years. An osteogenic sarcoma in the sellar region was reported 10 years after pituitary irradiation at 16 years of age by Amine and Sugar (1976) . Waltz and Brownell (1966) also found six cases of superficial sarcoma after head irradiation for other kinds of brain tumour. There have been two other cases (Berg et al., 1966) , and there are two reports of meningeal sarcoma after head irradiation (Schrantz and Aroaz, 1972; Komaki et al., 1977) . The first two cases of malignant schwannoma of the spine after irradiation of the back for unrelated conditions have been reported, and this tumour occurs very rarely (Maurice-Williams and Lucey, 1975) .
There are two previous accounts of glioma appearing after irradiation for other brain tumours. There was a patient with a left frontal angioblastic meningioma treated by partial removal and radiotherapy. Ten years later at necropsy the meningioma was still present but had become psammomatous, and there was a separate right frontal astrocytoma (Jones, 1960) . The other case was of a young adult whose craniopharyngioma was treated by surgery and radiotherapy and who died six years later of a glioblastoma multiforme of the temporal lobe (Komaki et al., 1977) . Cases 1 and 2 of this report are further instances of astrocytoma occurring long after irradiation and all the cases have been after irradiation in adult life. Case 2 had multiple consecutive neoplasms, meningioma, rectal cancer, and cerebral astrocytoma, and would be considered tumour prone (Moertal, 1966) . lonising radiations are known to be carcinogenic for man with a considerable latent period. After exposure to radiations in fetal life, a 10 year survey gives a reasonable estimate of the total induced disease. For those exposed in adult life a 25 year survey underestimates the lifetime risk of carcinogenesis by a factor of at least two. The hazards for the infant and child are closer to the adult than to the fetal one (Mole, 1973) . There have been various estimates of the late cancer risk, and one for whole-body irradiation is of the order of 200 cases per 106 exposed per rad (Mole, 1973) . When survivors of childhood malignancy who had been irradiated were followed, there was a cumulative probability of a second cancer of 12%. The radiation-related cancer rate was 1.8 cases in exposed tissues per 106 person-years per rad, with the peak incidence being 15 to 19 years after irradiation (Li et al., 1975) . A more recent estimate is of 10-4 cases per rad of whole-body dose, and when a single organ is irradiated the risk is lowered by a factor of at least four (World Health Organisation Report of Expert Committee, 1977) .
There is good evidence that moderate-dose irradiation of under 800 rad to the head in childhood is associated with a significant hazard of developing an intracranial meningioma many years later. With higher doses of irradiation, particularly when given in childhood, it would seem probable that there is still a risk of late meningioma. There might have been uncertainty about this and the occurrence of these new tumours could be within the bounds of normal expectancy. However, the evidence from the tinea capitis cases makes this unlikely. Thus ionising radiations are oncogenic for the meninges especially in childhood. This is the first positive example of such an induction agent being identified for meningeal tumours. Previously head trauma had been suggested as being responsible for some meningiomas, but the data never carried conviction (Russell and Rubinstein, 1971) . The matter of dose-dependency is complex. While there is a linear relationship between dose and the incidence of neoplasia, above a certain dose the rate begins to fall (Mole, 1973 (Mole, , 1975 . There is, for instance, evidence from the female pelvis that moderate doses of irradiation are more carcinogenic than high ones (Mole, 1973 (Mole, , 1975 Smith and Doll, 1976) .
So far there have been eight meningiomas after earlier irradiation and four astrocytomas. This is a reversal of the usual meningioma/glioma ratio, and is supporting evidence for ionising radiations being a meningeal carcinogen over a wide range of doses. The actual risks are very small. If therapeutic radiation gives, say, a fivefold increase in the meningioma rate over the expected, or a little above the tinea capitis ratio, then this would mean that in 100000 survivors from treatment in childhood and adolescence there would be around six meningiomas per year instead of the natural expectancy of one or so. This increase, a life-time one, would not be apparent until 10 years after treatment, and it might be 20 years before the maximum was reached. Further, many of these second tumours would be treatable. In those countries where irradiation on a wide scale was used for tinea capitis there should be an increased meningioma rate. The sarcoma risk, which is mainly an adult one and most common with pituitary radiation, seems to be due to a mixture of factors. The target tended to be small, high doses were often given over a short period of time, and multiple-course techniques used and which have now been abandoned. The risk with modern radiotherapeutic techniques is an exceedingly small one (Bloom, 1977) .
The evidence is less clear for brain astrocytoma being induced by ionising radiations, and if there is a hazard it is much smaller than the meningioma one. The few reported cases in adults might be within normal expectancy.
On available evidence there is nothing to indicate that the long-term neoplastic hazards of irradiation in any way outbalance the benefits of its calculated use for intracranial tumours at whatever age. However, its use for benign extracranial lesions of the head and neck cannot be supported at all (Cade, 1966 
